TrialSignal
Clinical trial intelligence report
Effect of Potato Fiber on Appetite and Fecal Fat Excretion
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT02957318-Jul 28, 2026
NCT ID
NCT02957318
Status
COMPLETED
Phase
Not Applicable (NA)
Sponsor
University of Copenhagen
Executive brief
Investment-Ready Snapshot
The study conducted by the University of Copenhagen explores the potential of potato-derived fibers in appetite suppression and fecal fat excretion, which may have implications for obesity management and weight control. The findings could position these dietary fibers as novel ingredients in functional foods and dietary supplements aimed at weight management. Given the increasing global focus on obesity and metabolic health, this research may attract interest from food manufacturers and nutraceutical companies. Competitive analysis should consider existing dietary fiber products and their efficacy in similar applications, as well as regulatory considerations for health claims associated with these fibers. Diligence should focus on the commercial viability of the FiberBind and RG-I fibers, including potential partnerships or licensing opportunities.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02957318
Indication
Fecal Fat Increased
Modality
protein therapy
Target
Viscous dietary fibers, specifically rhamnogalacturonan I (RG-I) and potato pulp (FiberBind), targeting appetite regulation and fecal fat excretion mechanisms.
Intervention
FiberBind, RG-I fiber, Placebo
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.